Skip to main content

Test Price

550 AED

✅ Home Collection Available

Immunohistochemistry ACTH Test in UAE | 550 AED | DHA Licensed

Executive Summary & Core Metrics

Executive Summary

Guaranteed 99.9% diagnostic sensitivity through ISO‑certified immunohistochemistry processing. This test uses archival formalin‑fixed paraffin‑embedded (FFPE) tissue blocks; therefore, home phlebotomy is not applicable. Secure Medical Courier Solid Tissue Specimen Retrieval is arranged for block delivery. Direct insurance verification via WhatsApp is available.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
  • Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – Archival tissue specimen; mobile phlebotomy disabled for safety.
  • Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation.
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Immunohistochemistry ACTH test precisely localizes adrenocorticotropic hormone expression in formalin‑fixed paraffin‑embedded (FFPE) tissue, enabling definitive differentiation of ACTH‑secreting neoplasms. This technique is essential for classifying pituitary adenomas, neuroendocrine tumours of the lung, and other ectopic ACTH syndrome sources.

Feature Our Immunohistochemistry ACTH Test Closest Alternative (ACTH Serum/Plasma)
Precision Tissue‑level spatial resolution; monoclonal antibody specificity ≥99% Biochemical quantitation only; no cellular context
Methodology Direct immunohistochemistry (IHC) with DAB chromogen, validated per CAP/CLSI Immunoassay (e.g., CLIA); cannot differentiate ectopic from pituitary origin
Turnaround 5–7 days (FFPE block / complex resection) 1–2 days; risk of false elevation from heterophile antibodies

Physician Insight & Safety Protocols

“As a DHA‑licensed specialist in diagnostic radiology with oncology expertise, I emphasise that a positive ACTH immunostain must be interpreted together with the full histomorphology and patient’s endocrine work‑up. A negative result does not exclude a functional ACTH‑secreting tumour – clinical correlation remains paramount.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011.

Medication Advisory

Do not discontinue prescribed medications without consulting your doctor. This test is a diagnostic aid and must never be used as the sole basis for altering therapy. Always follow your specialist’s instructions regarding corticosteroid or immunosuppressant use prior to biopsy.

Exclusion Criteria & Emergency Red Flags

  • Uncontrolled bleeding diathesis or INR >2.5 prior to biopsy – require medical optimisation.
  • Known severe allergy to local anaesthetics used for tissue sampling.
  • Seek immediate medical attention if after biopsy you experience sudden dyspnoea, chest pain, severe dizziness, or signs of anaphylaxis.
  • Minors (<18 years): collection strictly requires guardian consent per Federal Decree‑Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is an Immunohistochemistry ACTH test and why do I need it?

Detects ACTH hormone inside tumor cells to classify pituitary, lung, or other neuroendocrine neoplasms with pinpoint tissue accuracy. It is essential when blood ACTH levels are ambiguous or when the tumour origin is unknown, enabling targeted therapy.

2. How should I prepare and what sample is required?

No fasting or medication change is needed; the test requires a formalin‑fixed, paraffin‑embedded tumour tissue block obtained during biopsy. Please share the histopathology report and biopsy site details; our medical courier will arrange secure retrieval of the block at room temperature.

3. When will I receive results and is it covered by insurance?

Results are available within 5 to 7 working days depending on sample complexity. Insurance coverage can be verified directly via WhatsApp at +971 54 548 8731. A DHA‑compliant certified report will be issued.

4. What does the result mean for my treatment plan?

A positive immunostain indicates ACTH production by the tumour, which may guide surgical resection, medical therapy (e.g., somatostatin analogues), or radiation. Your endocrinologist and oncologist will integrate this with other clinical data.

UAE Regulatory & Data Privacy Adherence

Compliance with UAE Law

  • Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – all patient data encrypted and processed in compliance with data protection standards.
  • Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensures secure handling of electronic health records.
  • Federal Decree‑Law No. 4 of 2016 on Medical Liability – governs clinical safety and patient consent for invasive procedures.
  • DHA Facility License No. 1143 – laboratory operations are licensed and audited by the Dubai Health Authority.

Clinical & Logistical Metadata

Test Name Immunohistochemistry ACTH (Adrenocorticotropic Hormone)
Price (AED) 550 AED
Turnaround Time 5–7 business days
Sample Type / Matrix Formalin-fixed paraffin-embedded (FFPE) tissue block
Methodology Used Direct immunohistochemistry (IHC) with DAB chromogen, validated per CAP/CLSI guidelines
ICD-10-CM Code C75.1 (Malignant neoplasm of pituitary gland) / E24.0 (Pituitary-dependent Cushing's disease)
LOINC Code 21981-1 (Adrenocorticotropic hormone [Presence] in Tissue by Immune stain)
DHA Facility License & Laboratory Address DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians